| Mr Louis Lee Mizell Jr Jr, MD | |
|
74 E Kimballs Ln Ste 330, Draper, UT 84020-5006 | |
| (801) 545-8363 | |
| (801) 545-8133 |
| Full Name | Mr Louis Lee Mizell Jr Jr |
|---|---|
| Gender | Male |
| Speciality | Specialist |
| Location | 74 E Kimballs Ln Ste 330, Draper, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851396964 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0206X | Pediatrics - Pediatric Gastroenterology | 168364-1205 (Utah) | Secondary |
| 174400000X | Specialist | 82-168364-1205 (Utah) | Primary |
| Entity Name | Pediatrix Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730265919 PECOS PAC ID: 2567634587 Enrollment ID: O20190619000643 |
News Archive
In a new study by researchers at Yale Cancer Center, combining the immunotherapy drug durvalumab and PARP-inhibitor olaparib with chemotherapy improved response to treatment for women with high-risk, HER2-negative breast cancer, including a subset of estrogen receptor positive cancers.
Women who have difficulty getting pregnant often turn to in-vitro fertilization (IVF), but it doesn't always work. Now scientists are taking a new approach to improve the technique by studying the proteins that could help ready a uterus for an embryo to implant in its wall.
Medical Air Technology (MAT) understands that operating theatres are changing. As technology advances, and the possibilities of what can be achieved within the sterile environment expand, new designs are needed to accommodate new expectations.
BD Biosciences, a segment of BD, announced today a further expansion of its Research Grant program, adding $100,000 worth of reagents, cell culture tools and labware to support promising stem cell research.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Louis Lee Mizell Jr Jr, MD 5770 So 250 E, Suite 330, Murray, UT 84107 Ph: (801) 314-4455 | Mr Louis Lee Mizell Jr Jr, MD 74 E Kimballs Ln Ste 330, Draper, UT 84020-5006 Ph: (801) 545-8363 |
News Archive
In a new study by researchers at Yale Cancer Center, combining the immunotherapy drug durvalumab and PARP-inhibitor olaparib with chemotherapy improved response to treatment for women with high-risk, HER2-negative breast cancer, including a subset of estrogen receptor positive cancers.
Women who have difficulty getting pregnant often turn to in-vitro fertilization (IVF), but it doesn't always work. Now scientists are taking a new approach to improve the technique by studying the proteins that could help ready a uterus for an embryo to implant in its wall.
Medical Air Technology (MAT) understands that operating theatres are changing. As technology advances, and the possibilities of what can be achieved within the sterile environment expand, new designs are needed to accommodate new expectations.
BD Biosciences, a segment of BD, announced today a further expansion of its Research Grant program, adding $100,000 worth of reagents, cell culture tools and labware to support promising stem cell research.
› Verified 5 days ago